A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial.

Adv Ther · 2015 · PMC4349959 · PMID 25667132

Europe PMC DOI

hedged sentence

0.0970

closest p · 1.9× alpha

0.0970

boldest claim

The sentences

did not reach statistical significanceP = 0.097so close (0.05 < p ≤ 0.1)

The difference of height increase between males and females did not reach statistical significance ( P = 0.097).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.